Neuroblasztóma: vizsgálatok itt: Irán

1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

• 1. fázisTaking people
  Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

  Where

  Tehran

  Életkor

  2 év to 16 év

  People

  10

  Run by

  Marzieh Ebrahimi

  See details and how to joinNCT06674265